(Updated - May 19, 2026 8:01 AM EDT)

Benchmark analyst Bruce Jackson downgraded Biofrontera (NASDAQ: BFRI) from Buy to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE